Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Buy
12,794
+2,725
+27% +$29.3K ﹤0.01% 1621
2026
Q1
$85.2K Buy
+10,069
New +$110K ﹤0.01% 1588
2025
Q1
Sell
-6,148
Closed -$230K 1456
2024
Q4
$230K Buy
6,148
+1,263
+26% +$58.9K ﹤0.01% 1242
2024
Q3
$244K Buy
+4,885
New +$190K ﹤0.01% 1156
2024
Q2
Sell
-4,150
Closed -$227K 1326
2024
Q1
$227K Buy
+4,150
New +$205K ﹤0.01% 1147

Other funds holding BHVN

Xponance's BHVN Position: Q2 2026 in Review

Xponance increased its Biohaven (BHVN) stake by 27% in Q2 2026, buying an estimated $29.3K and bringing the position to 12,794 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Xponance first reported a position in BHVN in Q1 2024 and has held it in 5 quarters since. The position peaked at $244K in Q3 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Xponance held 12,794 shares of Biohaven worth $190K as of Q2 2026.
  • Xponance bought 2,725 Biohaven shares in Q2 2026, an estimated $29.3K.
  • Biohaven made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1621 holding.
  • Xponance first reported a position in Biohaven in Q1 2024 and has held it in 5 quarters since.
  • Xponance's Biohaven position peaked at $244K in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.